The WHO noted that its future guidelines will focus on how to identify and prioritize individuals with the greatest need
The American Association of Clinical Endocrinologists/American College of Endocrinology consensus statement also recommends either a GLP-1RA or SGLT2i as a preferred treatment option (either as first-line or, more typically, second-line treatment after metformin) over alternative options such as a dipeptidyl peptidase-4 inhibitor, a thiazolidinedione (TZD), or a sulfonylurea (SU), for patients with T2D and ASCVD, stage 3 CKD, or heart failure with reduced ejection fraction [2]
There are side effects to every medication, even approved medications, but when things are being touted as 100 percent safe, or you get all these great results, theres usually something fishy going on, Badon said
Weight typically returns gradually over 6 to 12 months after stopping semaglutide, though the rate varies individually
Overall, clinicians regard semaglutide as the more efficient and longer-acting drug [17, 18]
Pernicious anemia is a condition that makes it hard for your body to absorb vitamin B12